Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
»
Monthly archive
November 2011
Medivation Back to Neutral
Medivation Back to Neutral
Yahoo/Zacks
MDV3100
Medivation
prostate cancer
Inhibitex: The Negatives Of An Acquisition And The Odds Of It Occurring
Inhibitex: The Negatives Of An Acquisition And The Odds Of It Occurring
Seeking Alpha
Inhibitex
4-Star Stocks Poised to Pop: Sequenom
4-Star Stocks Poised to Pop: Sequenom
Motley Fool
Sequenom
Looking back at Immunex and ahead to Seattle's biotech future
Looking back at Immunex and ahead to Seattle's biotech future
bizjournals.com
Amgen
Transcept Wins FDA OK For Insomnia Drug, What's Next?
Transcept Wins FDA OK For Insomnia Drug, What's Next?
Seeking Alpha
FDA
insomnia
Intermezzo
Transcept
DEALTALK-Pfizer likely to spin off animal health -sources
DEALTALK-Pfizer likely to spin off animal health -sources
Reuters
animal health
M&A
Pfizer
Obama’s Medicare Chief Plans to Resign
Obama’s Medicare Chief Plans to Resign
Bloomberg
Medicaid
Medicare
Obama
Chronic Bowel Disease Drugs Linked to Skin Cancer Risk
Chronic Bowel Disease Drugs Linked to Skin Cancer Risk
Yahoo/Health Day
inflammatory bowel disease
skin cancer
thiopurines
Bayer YAZ To Follow Merck's Vioxx?
Bayer YAZ To Follow Merck's Vioxx?
Injuryboard.com
Merck
Vioxx
Yasmin
Yaz
Why Pfizer May Be About to Take Off
Why Pfizer May Be About to Take Off
Motley Fool
Pfizer
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT